海正生材：股东减持股份结果公告

Core Points - The announcement from Zhejiang Haizheng Biomaterials Co., Ltd. indicates that its major shareholder, Sinopec Capital, has reduced its stake in the company [2] - Sinopec Capital held 12,814,894 shares, representing 6.32% of the total share capital before the reduction [2] - As of November 11, 2025, Sinopec Capital has sold 2,026,700 shares through centralized bidding, which is 1% of the total share capital [2] - After the completion of the reduction plan, Sinopec Capital now holds 10,788,194 shares, accounting for 5.32% of the total share capital [2]